实验方案(Protocols)

SLC Core-Shell Monodispersed Magnetic Silica Microspheres Protocol

SLC core-shell Monodispersed Magnetic Silica Microspheres is a versatile, high-performance reagent designed to deliver rapid, reproducible magnetic separation across immunoassay, nucleic acid purification, and cell isolation workflows.

Product SKU
M120220
Particle Architecture
Core-shell: magnetic iron oxide core with silica shell
Size Uniformity
Monodispersed; low coefficient of variation for consistent performance
Surface Chemistry
Silica surface amenable to standard silane-based functionalization (e.g., –NH₂, –COOH, –epoxy)
Magnetic Response
Rapid magnetic separation achievable with standard permanent magnet or magnetic rack
Recommended Storage
Store at 4 °C in aqueous suspension; avoid freezing and desiccation
Key Applications
Immunoassay, nucleic acid purification, cell isolation, biosensor development

Product Overview and Principle

SLC core-shell Monodispersed Magnetic Silica Microspheres (SKU: M120220) are engineered particles consisting of a superparamagnetic iron oxide core encapsulated within a uniform silica shell. This architecture combines the rapid magnetic responsiveness of iron oxide with the chemically versatile and biocompatible surface properties of silica.

The monodispersed size distribution ensures reproducible binding kinetics, low non-specific adsorption, and consistent batch-to-batch performance—critical attributes for quantitative assay development and automated workflows. The silica surface presents abundant silanol (Si–OH) groups that serve as anchoring points for downstream functionalization with a broad range of silane coupling agents.

Upon application of an external magnetic field, the microspheres migrate rapidly to the vessel wall, enabling supernatant removal and washing steps without centrifugation. Once the field is removed, the particles readily resuspend due to their superparamagnetic character and absence of magnetic remanence.

Materials Required

  • SLC core-shell Monodispersed Magnetic Silica Microspheres (M120220), supplied as aqueous suspension
  • Appropriate binding/wash buffer (e.g., PBS pH 7.4, or buffer suited to specific application)
  • Magnetic separation rack or permanent magnet compatible with tube format in use
  • Microcentrifuge tubes (1.5 mL or 2.0 mL) or appropriate reaction vessels
  • Micropipettes and low-binding pipette tips
  • Vortex mixer and/or rotary end-over-end mixer
  • Temperature-controlled incubator or heat block (if required by application)
  • Target biomolecule (antibody, oligonucleotide, or other ligand) for conjugation if performing functionalization
  • Coupling reagents appropriate to chosen surface chemistry (e.g., EDC/NHS for –COOH surfaces, glutaraldehyde for –NH₂ surfaces)

Step-by-Step Protocol

Step 1 – Preparation of Microsphere Suspension

  1. Remove the product vial from storage (4 °C) and allow it to equilibrate to room temperature for approximately 10 minutes.
  2. Resuspend the microspheres thoroughly by vortexing for 30 seconds followed by gentle end-over-end rotation for 2 minutes. Ensure no visible aggregates remain.
  3. Transfer the required volume of microsphere suspension to a fresh microcentrifuge tube.

Step 2 – Magnetic Wash (Pre-Equilibration)

  1. Place the tube on the magnetic rack for 2–3 minutes until the microspheres are fully captured against the tube wall and the supernatant is clear.
  2. Carefully aspirate and discard the supernatant without disturbing the microsphere pellet.
  3. Remove the tube from the magnet and immediately add the appropriate working buffer (e.g., 500 µL PBS pH 7.4).
  4. Resuspend by vortexing briefly (5–10 seconds) and end-over-end rotation for 1 minute.
  5. Repeat the magnetic wash step once more for a total of two pre-equilibration washes.

Step 3 – Binding / Functionalization

  1. After the final wash, remove the supernatant magnetically and resuspend the microspheres in the binding buffer at the desired concentration.
  2. Add the target biomolecule or coupling reagent according to the requirements of the specific application or functionalization chemistry.
  3. Incubate under appropriate conditions (temperature, time, and agitation as dictated by the application). End-over-end rotation is recommended to maintain particle suspension during incubation.
  4. Following incubation, place on the magnetic rack for 2–3 minutes and remove the supernatant.

Step 4 – Washing and Elution

  1. Resuspend the microspheres in wash buffer and mix for 1–2 minutes.
  2. Apply magnetic separation (2–3 minutes) and aspirate the wash supernatant.
  3. Repeat washing 2–3 times or as optimised for the specific application.
  4. For elution of captured target molecules, resuspend the washed microspheres in elution buffer (composition dependent on application, e.g., low-pH glycine buffer for antibody–antigen systems, heated water or low-salt buffer for nucleic acids).
  5. After elution incubation, magnetically separate the microspheres and collect the eluate containing the target analyte.

Step 5 – Storage of Used or Unused Microspheres

  1. Unused microspheres should be stored as received at 4 °C in their original aqueous suspension. Do not freeze.
  2. If the microspheres are to be reused (application-dependent), wash thoroughly in storage buffer and store at 4 °C. Assess performance before reuse in critical assays.

Troubleshooting

ProblemLikely CauseSuggested Action
Poor or slow magnetic separationInsufficient magnet strength; particle aggregation; buffer contains chelating agents affecting magnetic coreUse a higher-field magnetic rack; ensure buffer is free of EDTA or strong chelators; verify particle resuspension before use
High non-specific binding / backgroundInsufficient blocking; suboptimal wash stringencyInclude a blocking step (e.g., BSA or casein) after functionalization; increase number or duration of wash steps; optimise salt/detergent concentration in wash buffer
Low target capture efficiencySuboptimal incubation conditions; insufficient ligand density on surfaceOptimise incubation time, temperature, and buffer pH; increase ligand-to-microsphere ratio during coupling; confirm coupling efficiency by spectrophotometric measurement of supernatant
Particle aggregationIonic strength or pH incompatibility; drying of particles during handlingMatch buffer ionic strength and pH to product specifications; never allow particles to dry out; store in aqueous suspension at 4 °C
Loss of particles during washingMagnet contact time too short; premature supernatant removalExtend magnet contact time to ≥3 minutes; ensure supernatant is fully clear before aspiration

Safety, Handling, and Regulatory Notes

General Handling: SLC core-shell Monodispersed Magnetic Silica Microspheres are intended for research use only (RUO). They are not approved for diagnostic, therapeutic, or clinical use in humans or animals.

Physical Hazards: The product contains iron oxide nanoparticles. Avoid inhalation of any dried particulate. Work in a well-ventilated area and wear appropriate personal protective equipment (lab coat, gloves, and eye protection) when handling.

Magnetic Precautions: When using strong external magnets, keep away from electronic devices, implanted medical devices (e.g., pacemakers), and magnetic storage media.

Disposal: Dispose of all waste in accordance with local institutional and governmental regulations for chemical and biological waste.

SDS: Consult the Safety Data Sheet (SDS) for M120220 available from Aladdin Scientific prior to use. The SDS contains current information on hazard classification, first-aid measures, and emergency contacts.

Frequently asked questions

What buffer is recommended for resuspending and storing SLC magnetic silica microspheres?

The microspheres are typically supplied and stored as an aqueous suspension. For most applications, a physiologically compatible buffer such as PBS (pH 7.4) is suitable for working resuspension. Avoid buffers containing strong chelating agents (e.g., high concentrations of EDTA) as these may affect the iron oxide core over time. Always refer to the product datasheet for application-specific buffer recommendations.

Can SLC core-shell magnetic silica microspheres be conjugated to antibodies or other proteins?

Yes. The silica surface can be functionalized with silane coupling agents to introduce reactive groups such as –NH₂, –COOH, or –epoxy, enabling covalent conjugation of antibodies, streptavidin, enzymes, oligonucleotides, or other biomolecules. Standard bioconjugation chemistries (e.g., EDC/NHS coupling for carboxylated surfaces) are compatible with this product. Optimization of coupling conditions, including pH, temperature, and reagent ratios, is recommended for each specific ligand.

How long does magnetic separation take, and what type of magnet is required?

In most cases, magnetic separation is achieved within 2–3 minutes using a standard permanent-magnet separation rack designed for 1.5 mL or 2.0 mL microcentrifuge tubes. Separation time may vary depending on particle concentration, tube geometry, and buffer viscosity. For larger volumes or different vessel formats, a magnet with sufficient field strength should be selected accordingly.

Is it possible to freeze SLC magnetic silica microspheres for long-term storage?

Freezing is not recommended. Ice crystal formation during freezing can cause irreversible particle aggregation, compromising monodispersity and performance. The recommended storage condition is 4 °C in aqueous suspension. For long-term storage, ensure the suspension does not dry out and is kept away from contaminants.

What applications are SLC core-shell monodispersed magnetic silica microspheres suitable for?

These microspheres are suitable for a broad range of research applications, including immunomagnetic cell isolation, nucleic acid extraction and purification, enzyme immobilization, protein purification, lateral flow assay development, and biosensor platforms. Their monodispersed size distribution and chemically versatile silica surface make them adaptable to diverse downstream functionalization and assay formats.

References

  1. Aladdin Scientific. M120220 – SLC core-shell Monodispersed Magnetic Silica Microspheres. Product Information Sheet. Aladdin Scientific.
  2. Gupta, A.K. & Gupta, M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26(18), 3995–4021. doi:10.1016/j.biomaterials.2004.10.012
  3. Laurent, S. et al. (2008). Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations and biological applications. Chemical Reviews, 108(6), 2064–2110. doi:10.1021/cr068445e

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《SLC Core-Shell Monodispersed Magnetic Silica Microspheres Protocol》. 阿拉丁知识库,更新于 2026年10月24日。 https://www.aladdin-e.com/zh_cn/faqs/slc-core-shell-monodispersed-magnetic-silica-microspheres-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助